WASHINGTON, Nov 12 (Reuters) - Alpharma Inc's (ALO.N: Quote, Profile, Research, Stock Buzz) powerful painkiller Embeda may not thwart drug abusers despite design features aimed at curbing misuse, U.S. regulatory staff said in documents released on Wednesday.
